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Summary
Background.  —  Compensatory  mechanisms  activated  after  myocardial  infarction  include  an
increase in  systolic  wall  stress  (SWS)  and  activation  of  the  neurohormonal  system.  Nevertheless,
left ventricular  ejection  fraction  (LVEF)  and  infarct  size  are  the  established  primary  predictorsMyocardial  infarction of outcome  after  ST-segment  elevation  myocardial  infarction.
Aims. —  To  assess  the  relative  impact  of  various  cardiac  magnetic  resonance  (CMR)  imaging
variables, such  as  infarct  size,  LVEF  and  SWS,  on  pre-  and  post-discharge  heart  failure  (HF).
Methods. —  CMR  was  performed  in  a  prospective  study  involving  169  patients  with  ﬁrst  ST-
segment elevation  myocardial  infarction.  Common  CMR  ﬁndings,  such  as  SWS,  were  computed.
Abbreviations: CI, conﬁdence interval; CMR, cardiac magnetic resonance; HF, heart failure; HR, hazard ratio; LGE, late gadolinium
nhancement; LVEF, left ventricular ejection fraction; LVR, left ventricular remodelling; MVO, microvascular obstruction; OR, odds ratio;
BP, systolic blood pressure; SWS, systolic wall stress.
∗ Corresponding author. Laboratoire cardioprotection, remodelage et thrombose, UPRES EA 3860, faculté de médecine, rue Haute de
eculée, 49045 Angers cedex 1, France.
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Results.  —  Mean  SWS  was  16.3  ±  5.1  ×  103 N·m−2,  and  was  systematically  higher  in  patients
exhibiting  either  pre-  or  post-discharge  HF  (18.9  ±  5.7  and  21.3  ±  7.6  ×  103 N·m−2,  respectively).
SWS was  moderately  related  to  initial  infarct  size  (r  =  0.405;  P  <  0.001).  In  total,  28  patients  pre-
sented with  HF  during  the  hospitalization  phase  and  14  during  follow-up,  with  a  median  time
of event  of  93  days  (25th—75th  percentiles,  29—139.25  days).  The  univariate  predictors  of  HF
were age,  LVEF,  infarct  size,  SWS,  microvascular  obstruction,  anterior  infarction  and  heart  rate
at admission.  Multivariable  analysis  revealed  infarct  size  and  age  to  be  the  predictors  of  pre-
discharge HF,  while  SWS  and  heart  rate  at  admission  predicted  post-discharge  HF.  The  greatest
SWS quartile  provided  a  negative  predictive  value  of  95.9%.
Conclusion.  —  Regardless  of  LVEF  and  infarct  size,  SWS  was  shown  to  be  an  independent  predic-
tor of  post-discharge  HF  after  ST-segment  elevation  myocardial  infarction.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  La  survenue  d’un  infarctus  du  myocarde  est  responsable  d’une  augmentation  du
stress pariétal  systolique  (SWS)  et  de  l’activation  du  système  neurohormonal.  Cependant,  la
fraction d’éjection  du  ventricule  gauche  et  la  taille  d’infarctus  restent  les  deux  principaux
déterminants  d’événements  cliniques  au  décours.
Objectifs.  —  Nous  avons  cherché  à  établir  l’impact  relatif  de  différents  paramètres  issus  de
l’IRM cardiaque  tels  que  la  taille  d’infarctus,  la  fraction  d’éjection  et  le  SWS,  et  ceci  à  la  fois
sur la  survenue  d’épisode  d’insufﬁsance  cardiaque  au  cours  de  la  phase  hospitalière,  mais  aussi
au cours  du  suivi  ultérieur.
Méthodes.  —  Une  analyse  par  IRM  cardiaque  a  été  réalisée  à  la  phase  hospitalière  et  répétée
à 3  mois  chez  169  patients  consécutifs  présentant  un  infarctus  du  myocarde  inaugural  avec
élévation  du  segment  ST.
Résultats.  —  Vingt-huit  patients  ont  présenté  un  épisode  d’insufﬁsance  cardiaque  lors  de
l’hospitalisation  initiale  et  14  pendant  leur  suivi  avec  une  médiane  de  survenue  de
93 jours  (25e—75e percentiles,  29—139,25  jours).  La  valeur  moyenne  du  SWS  était  de
16,3 ±  5,1  ×  103 N·m−2 et  était  retrouvée  systématiquement  plus  élevée  chez  les  patients  qui
présentaient  un  épisode  d’insufﬁsance  cardiaque,  que  ce  soit  hospitalier  ou  lors  du  suivi  (res-
pectivement  18,9  ±  5,7  et  21,3  ±  7,6).  Le  SWS  était  faiblement  corrélé  à  la  taille  d’infarctus
initiale (r  =  0,405  ;  p  <  0,001).  L’analyse  multivariée  montrait  que  la  taille  d’infarctus  et  l’âge
étaient les  paramètres  prédictifs  de  la  survenue  d’insufﬁsance  cardiaque  lors  de  la  phase  hos-
pitalière  alors  que  le  SWS  et  la  fréquence  cardiaque  à  l’admission  prédisaient  la  survenue  d’une
insufﬁsance  cardiaque  au  cours  du  suivi  ultérieur.  Le  SWS  le  plus  élevé  (4e quartile)  présentait
une valeur  prédictive  négative  de  95,9  %.
Conclusion.  —  Quelles  que  soient  les  fractions  d’éjection  et  taille  d’infarctus,  le  stress  pariétal
systolique  est  un  paramètre  prédictif  indépendant  de  la  survenue  d’insufﬁsance  cardiaque  au
cours du  suivi  des  patients  ayant  présenté  un  infarctus  du  myocarde  avec  le  sus-décalage  du
segment  ST.
©  2015  Elsevier  Masson  SAS.  Tous  droits  réservés.
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The  current  modalities  used  to  manage  acute  myocardial
infarction  with  ST-segment  elevation  have  improved  patient
survival  rates  [1,2].  Nevertheless,  the  loss  of  contractile
performance  is  still  accompanied  by  an  increase  in  neuro-
hormonal  activity  and  wall  stress;  these  are  exerted  on  both
infarcted  and  healthy  remote  myocardial  areas,  and  induce
both  metabolic  and  histological  changes  [3,4].  An  excessive
increase  in  these  compensatory  mechanisms  induces  left
ventricular  remodelling,  with  left  ventricular  enlargement
being  a  precursor  of  heart  failure  (HF)  and  death.  HF  is,  in
a
t
sact,  the  most  common  event  during  post-myocardial  infarc-
ion  patient  management,  and  remains  a  matter  of  grave
ublic  health  concern.
Over  the  last  few  decades,  cardiac  imaging  has  been
peciﬁcally  dedicated  to  assessing  individual  prognosis  issues
5], with  a  large  range  of  variables  described.  Some  are  func-
ional,  such  as  left  ventricular  ejection  fraction  (LVEF)  and
eft  ventricular  volumes  [6],  others  are  directly  related  to
he  ischaemic  injury  in  question,  such  as  infarct  size  [7,8], factor  that  was  even  considered  a  surrogate  marker  for
herapeutic  efﬁcacy,  while  others  are  related  to  reperfu-
ion  success,  such  as  microvascular  obstruction  assessment
3[
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9,10].  Alongside  these  variables,  and  given  the  fact  that
eft  ventricular  remodelling  (LVR)  implicates  changes  in  left
entricular  shape  that  may  be  investigated  through  geomet-
ical  factors,  we  wished  to  share  our  interest  in  evaluating
nd-systolic  wall  stress  (SWS).  This  may,  in  fact,  be  consid-
red  a  load-dependent  functional  variable,  and  was  found
o  be  independently  related  to  cardiovascular  prognosis  [11]
nd,  more  precisely,  HF  events.
In  this  study,  we  evaluated  acute  myocardial  infarc-
ion  patients  with  the  aim  of  determining  which  cardiac
agnetic  resonance  (CMR)  variables  out  of  left  ventricu-
ar  SWS,  infarct  size  and  MVO,  assessed  during  the  initial
hase  are  independent  predictors  of  HF  at  both  pre-  and
ost-discharge  levels.
ethods
tudy population
 total  of  169  patients  with  acute  myocardial  infarction,
eferred  to  our  catheterization  laboratory  for  emergency
rimary  transcutaneous  coronary  angioplasty,  were  eval-
ated  prospectively.  Patients  were  enrolled  if  they  met
he  following  criteria:  ST-segment  elevation  myocardial
nfarction  within  12  hours  of  chest  pain  onset;  success-
ul  angioplasty  with  stent  implantation;  written  informed
onsent  provided.  The  exclusion  criteria  were  as  follows:
istory  of  myocardial  infarction  or  coronary  bypass  graft-
ng;  age  <  18  years;  clinical  signs  of  cardiogenic  shock;  major
o-morbidities  limiting  life  expectancy;  contraindications
or  CMR  (pacemaker,  metallic  devices,  claustrophobia  or
hronic  renal  insufﬁciency).  This  study  conformed  to  the
rinciples  outlined  in  the  declaration  of  Helsinki.  All  patients
rovided  written  informed  consent  for  completion  of  the
MR,  and  the  study  protocol  was  approved  by  the  hospital’s
thics  committee  (CHU  Angers).
maging technique
MR  was  performed  using  a  1.5  Tesla  imager  (Avanto,
iemens,  Erlangen,  Germany)  with  the  application  of  an
ight-element  phased-array  cardiac  receiver  coil.  All  imag-
ng  was  obtained  at  the  end  of  expiration  in  order  to
educe  the  ventricular  volume  changes  induced  by  Valsalva
anoeuver  in  forced  inspiration.  Left  ventricular  func-
ion  was  analysed  using  the  steady-state  free  precession
equence  performed  on  contiguous  short-axis  slices  cover-
ng  the  entire  left  ventricle.  The  typical  in-plane  resolution
pplied  was  1.6  ×  1.9  mm,  with  a  7  mm  section  thickness
repetition  time/echo  time,  2.6  ms/1.30  ms;  ﬂip  angle,  80◦;
atrix,  256  ×  208;  temporal  resolution,  35—45  ms).
Late  gadolinium  enhancement  (LGE)  sequences  were  per-
ormed  12—15  minutes  after  the  injection,  at  a dose  of
.2  mmol/kg,  by  means  of  a  two-dimensional  segmented
nversion  recovery  gradient-echo  pulse  sequence.  An  initial
nversion  time  scout  sequence  was  conducted  to  determine
he  optimal  inversion  time.  Contiguous  short-axis  slices  cov-
red  the  entire  ventricle.  The  typical  in-plane  resolution
sed  was  1.68  ×  1.68  mm,  with  a  7  mm  section  thickness
echo  time,  4.66  ms;  ﬂip  angle,  30◦;  imaging  triggered  to
very  other  heartbeat;  matrix,  256  ×  208).  Steady-state
t
t
f
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ree  precession  pulse  sequences  and  LGE  sequences  were
cquired  in  breathhold  state,  each  with  identical  section
ositioning.
mage analysis
he  CMR  images  were  transferred  to  a  workstation  for
nalysis  and  calculation  (QMass  7.1,  Medis,  Leiden,  The
etherlands).
eft ventricular function
n  all  short-axis  cine  slices,  the  endocardial  and  epicar-
ial  borders  were  outlined  manually  on  end-diastolic  and
nd-systolic  images,  excluding  the  trabeculae  and  papillary
uscles.  Left  ventricular  end-diastolic  and  end-systolic  vol-
mes,  such  as  left  ventricular  mass,  were  determined.
nfarct size measurement
nfarct  size  was  quantiﬁed  on  LGE  images  by  means  of  the
full  width  at  half  maximum’  method  [12], corresponding  to
he  sum  of  the  LGE  extent  measured  on  all  sections,  given
n  grams.
icrovascular assessment
f  present,  central  hypoenhancement  was  manually  delin-
ated,  and  its  extent  was  systematically  added  to  the
yperenhanced  area.  The  variability  assessment  for  left  ven-
ricular  volumes,  infarct  size  and  MVO  extent  produced  good
esults,  published  elsewhere  [12,13].
all stress measurement
lobal  wall  stress  was  calculated  using  dedicated  software,
pecially  built  by  our  laboratory,  using  a  three-dimensional
odel  analysis  [14,15].  In  brief,  a  median  border  between
ndo-  and  epicardial  borders  was  generated  on  each  slice.
he  barycentre  of  the  section  was  then  deﬁned  as  the  mass
entre  of  the  median  border.  Each  short-axis  was  centred
n  the  barycentre.  The  radius  of  curvature  and  wall  thick-
ess  were  calculated  on  end-systole  in  a  series  of  contiguous
hort-axis  slices  (5—12  sections,  depending  on  heart  size)  in
rder  to  compute  the  SWS  [16,17]. All  apical  slices  absent  of
entricular  cavity  and  basal  slices  presenting  open  borders
ere  excluded  from  the  analysis.  The  SWS  was  calculated
n  each  slice,  with  the  SWS  of  the  whole  heart  (global  wall
tress),  deﬁned  as  the  average  value  of  all  slices,  then  used
or  the  statistical  analyses.
Wall  stress  was  calculated  using  the  modiﬁed  Grossman
ormula  [18]:  0.133  ×  SBP  ×  (R/[2Wt  ×  (1  +  Wt/2R)]),  where
BP  is  systolic  blood  pressure,  R  is  radius  of  curvature  and  Wt
s  wall  thickness.  Three  measurements  were  taken  from  the
BP  cuff  during  the  acquisition  of  cine  magnetic  resonance
maging.
utcome measures
utcomes  were  deﬁned  by  a  consensus  achieved  between
wo  physicians  blinded  to  the  CMR  results  in  accordance  with
he  ESC  guidelines  [19].  We  distinguished  between  deaths
rom  cardiovascular  causes  and  other  causes.  Death  and  hos-
italization  for  HF  were  tabulated  per  subject.  Patients  who
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died  were  judged  irrelevant  for  the  HF-dedicated  analy-
sis  and  thus  excluded.  We  reported  all  cases  of  HF  during
hospitalization  and  follow-up.
Statistical analysis
Data  are  presented  as  means  ±  standard  deviations  or
medians  (25th—75th  percentiles)  in  cases  of  non-normal  dis-
tribution,  with  categorical  data  expressed  as  frequencies
and  percentages.  Comparisons  of  variables  were  performed
using  analysis  of  variance,  the  unpaired  Student’s  t-test  or
the  Chi2 test,  where  appropriate.  We  compared  the  baseline
with  3-month  quantitative  CMR  variables  by  means  of  the
Wilcoxon  test.  Initial  and  follow-up  CMR  ﬁndings  were  com-
pared  with  initial  SWS  and  infarct  size  using  the  Pearson’s
correlation  coefﬁcient.  A  stepwise  binomial  logistic  regres-
sion  analysis  was  performed  to  identify  the  determinants  of
SWS.  LVEF  and  left  ventricular  volumes  were  not  included  in
the  model  because  of  a  high  level  of  collinearity.
For  multivariable  analysis  assessing  HF  during  hospital-
ization,  clinical  and  CMR  data  were  tested  by  means  of
a  stepwise  binomial  logistic  regression  analysis,  including
variables  with  P  values  <  0.05.  The  Hosmer-Lemeshow  statis-
tic  was  used  to  assess  the  goodness-of-ﬁt  of  the  applied
models.  A  similar  analysis  was  performed  to  identify  pre-
dictors  of  any  level  of  HF.
For  multivariable  analysis  assessing  HF  during  follow-up,
clinical  and  CMR  data  were  tested  by  means  of  a  stepwise
Cox  analysis,  including  variables  with  P  values  <  0.05.  The
proportional-hazard  assumptions  were  tested  by  analysing
the  Schoenfeld  residuals.
The  analyses  were  performed  using  SPSS  version  15.0  for
Windows  (SPPS  Inc.,  Chicago,  IL,  USA).  A  P  value  <  0.05  was
considered  statistically  signiﬁcant.
Results
Patient characteristics in terms of heart
failure
This  study  included  169  patients  presenting  with  a  ﬁrst
episode  of  acute  myocardial  infarction  with  persistent  ST-
segment  elevation,  referred  between  January  2008  and
May  2012.  The  patient  characteristics  are  summarized  in
Table  1.  We  observed  that  the  population  with  pre-  and
post-discharge  HF  exhibited  more  anterior  infarctions  with
higher  creatine  kinase  peaks  (75.0%  with  4839  ±  2643  IU/L
and  85.7%  with  5709  ±  2935  IU/L,  respectively).  Discharge
treatments  systematically  combined  dual  anti-platelet
aggregation,  angiotensin-converting  enzyme  inhibitors  and
statins.  Two  patients  were  not  administered  beta-blocker
treatment  because  of  a  history  of  asthma;  57  patients
(33.7%)  received  an  aldosterone  blocker.
Cardiac magnetic resonance ﬁndings
CMR  was  performed  at  5  days  (4—8  days)  post-infarction  and
repeated  at  98  days  (93—104).  No  images  were  excluded
from  the  analysis.  The  majority  of  CMR  variables  were  more
pejorative  in  cases  of  pre-  or  post-discharge  HF,  including
LVEF,  SWS,  infarct  size  and  MVO  presence  or  extent  (Table  2).
I
v
p
tigure 1. Scatter plot showing the relationship between initial
nfarct size and systolic wall stress (SWS) measured by cardiac mag-
etic resonance imaging.
SWS  was  moderately  related  to  initial  infarct  size
r  =  0.405;  P  <  0.001)  (Fig.  1).  SWS  had  a stronger  correla-
ion  with  left  ventricular  end-diastolic  volume  index,  left
entricular  end-systolic  volume  index  and  LVEF  (r  =  0.548,
.730  and  —0.674,  respectively;  P  <  0.001)  than  did  ini-
ial  infarct  size  (r  =  0.263,  0.605  and  —0.765,  respectively;
 <  0.001)  (Fig.  2).  Table  3  shows  the  baseline  characteristics
ccording  to  SWS  quartile.  Binomial  logistic  analysis  showed
nfarct  size  (odds  ratio  [OR]  1.063,  95%  conﬁdence  inter-
al  [CI]  1.029—1.097;  P  <  0.001)  and  age  (OR  1.046,  95%  CI
.010—1.082;  P  =  0.011)  to  be  markers  of  SWS.
At  follow-up,  an  absolute  decrease  of  19.0%  was  observed
n  infarct  size  (P  <  0.001)  and  of  5.0%  was  observed  in  left
entricular  end-systolic  volume  index  (P  <  0.001),  while  LVEF
ncreased  by  7.2%  (P  <  0.001)  and  SWS  by  10.3%  (P  <  0.001).
atients  with  any  form  of  HF  presented  with  higher  SWS.
WS  and  changes  in  SWS  were  even  more  elevated  in  post-
ischarge  HF  patients  (Table  2).
utcomes
ollow-up  lasted  a median  of  917  days  (492—1260  days)  after
he  initial  infarction.  Cardiovascular  death  occurred  in  three
ases  (one  endocarditis,  one  ventricular  rupture  and  one
nexplained  sudden  death)  and  non-cardiovascular  deaths
ccurred  in  three  other  cases  (end-stage  neoplasm).  A  total
f  28  patients  displayed  predischarge  HF,  compared  with
4  presenting  HF  during  follow-up,  with  a  median  time  of
vent  of  93  days  (29—139.25  days).  Of  these  latter  cases,  12
86%)  were  reported  within  the  sixth  month  of  follow-up.  It
s  worth  noting  that  seven  patients  exhibited  both  pre-  and
ost-discharge  HF.
nivariate and multivariable predictors of
eart failuren  addition  to  common  CMR  functional  variables,  such  as  left
entricular  volumes  and  LVEF,  the  univariate  predictors  of
re-  and  post-discharge  HF  were  age,  anterior  infarc-
ion,  heart  rate,  infarct  size,  MVO  and  baseline  SWS.
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Table  1  Baseline  clinical  characteristics  of  the  population  according  to  heart  failure  event.
Total  No  predischarge  HF  Predischarge  HF
(n  =  28)
Pa No  post-discharge  HF  Post-discharge  HF
(n  =  14)
Pa
Age  (years)  58.0  ±  11.6  56.8  ±  10.9  61.3  ±  13.0  0.001  57.0  ±  11.3  62.0  ±  14.2  0.18
BMI  (kg/m2)  27.2  ±  4.1  26.8  ±  4.0  28.9  ±  4.3  0.011  27.2  ±  4.1  26.7  ±  4.5  0.68
Risk  factors
Male  140  (85.9)  117  (86.7)  23  (82.1)  0.36  128  (85.9)  12  (85.7)  0.62
Hypertension  58  (35.6)  44  (32.6)  14  (50.0)  0.07  50  (33.6)  8  (57.1)  0.07
Diabetes  mellitus 25  (15.3)  21  (15.6)  4  (14.3)  0.56  22  (14.8)  3  (21.4)  0.37
Hypercholesterolaemia  86  (52.8)  70  (51.9)  16  (57.1)  0.38  79  (53.0)  7  (50.0)  0.52
Tobacco  use  74  (45.4)  62  (45.9)  12  (42.9)  0.89  69  (46.3)  5  (35.7)  0.41
Characteristics  at  admission
SBP  (mmHg)  141.2  ±  26.9  141.0  ±  25.6  142.1  ±  32.8  0.84  141.4  ±  27.3  138.8  ±  21.7  0.73
Heart  rate  (beats/min)  75.5  ±  18.5  75.5  ±  17.9  75.5  ±  21.4  0.98  74.4  ±  17.7  87.1  ±  22.6  0.012
LAD  culprit  lesion  91  (55.8)  70  (51.9)  21  (75.0)  0.019  79  (53.0)  12  (85.7)  0.016
Multivessel  disease  73  (44.8)  61  (45.1)  12  (42.8)  0.38  68  (45.6)  5  (35.7)  0.75
Creatinine  (mol/L) 84.1  ±  27.1  82.6  ±  27.2  91.5  ±  26.3  0.11  82.3  ±  20.6  104.2  ±  62.4  0.003
Blood  glucose  (mmol/L)  9.0  ±  6.3  8.9  ±  6.7  9.4  ±  3.8  0.67  8.9  ±  6.5  9.3  ±  3.0  0.83
Creatine  kinase  peak  (IU/L)  3085  ±  2196  2718  ±  1908  4839  ±  2643  <  0.001  2836  ±  1950  5709  ±  2935  <  0.001
HbA1c  (%)  6.2  ±  1.3  6.2  ±  1.3  6.2  ±  1.4  0.76  6.2  ±  1.3  6.0  ±  0.8  0.59
Haemoglobin  (g/dL)  15.0  ±  1.6  15.0  ±  1.5  15.0  ±  2.0  0.86  14.9  ±  1.5  15.5  ±  2.4  0.26
Data are mean ± standard deviation or number (%). BMI: body mass index; HbA1c: glycated haemoglobin; HF: heart failure; LAD: left anterior descending artery; SBP: systolic blood
pressure.
a Comparison of patients with and without HF.
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Table  2 Cardiac  magnetic  resonance  variables  in  terms  of  heart  failure  event.
Total No  predischarge  HF Predischarge  HF
(n  =  28)
Pa No  post-discharge  HF Post-discharge  HF
(n  =  14)
Pa
Initial  CMR  assessment
LVEDV  index  (mL/m2) 86.2  ±  17.2 85.3  ±  16.7 90.5  ±  19.1 0.14  84.8  ±  16.2 100.3  ±  21.2 0.001
LVESV  index  (mL/m2) 46.1  ±  15.5 44.1  ±  14.4 55.7  ±  17.6 <  0.001 44.3  ±  13.6 65.2  ±  21.9 <  0.001
LVEF  (%) 47.3  ±  10.0 49.0  ±  9.3 39.4  ±  9.9 <  0.001 48.4  ±  9.1 36.4  ±  13.0 <  0.001
LV  mass  index  (g/m2) 58.5  ±  11.7 57.2  ±  10.5 64.8  ±  15.0 0.001  57.9  ±  11.8 64.7  ±  8.6 0.038
Infarct  size  (%) 21.8  ±  13.0 19.7  ±  12.4 31.8  ±  11.3 <  0.001 20.7  ±  12.0 33.6  ±  18.4 <  0.001
MVO  96  (58.9) 75  (56.0) 21  (77.8) 0.027  84  (56.8) 12  (92.3) 0.009
MVO  (g)  2.7  ±  4.8  2.1  ±  3.7  6.0  ±  7.8  <  0.001  2.3  ±  3.8  7.4  ±  10.2  <  0.001
SWS  (103·N·m−2)  16.3  ±  5.1  15.7  ±  4.8  18.9  ±  5.7  0.002  15.8  ±  4.6  21.3  ±  7.6  <  0.001
Follow-up  CMR  assessment
LVEDV  index  (mL/m2)  86.9  ±  20.0  85.2  ±  19.0  95.2  ±  22.7  0.016  83.8  ±  16.2  119.3  ±  26.4  <  0.001
LVESV  index  (mL/m2)  43.8  ±  18.0b 41.4  ±  15.9  55.5  ±  22.8  <  0.001  40.7  ±  13.7  75.2  ±  26.3  <  0.001
LVEF  (%)  50.8  ±  10.0 b 52.3  ±  9.2  43.6  ±  11.1  <  0.001  52.0  ±  9.0  38.6  ±  12.0  <  0.001
LV  mass  index  (g/m2)  53.3  ±  9.6  52.8  ±  9.5  56.0  ±  9.9  0.11  52.8  ±  9.5  59.0  ±  8.8  0.020
Infarct  size  (%)  17.5  ±  11.2b 16.2  ±  11.2  23.8  ±  9.5  0.001  16.5  ±  10.3  27.3  ±  15.8  <  0.001
SWS  (103·N·m−2)  18.0  ±  6.9b 17.0  ±  6.0  22.9  ±  9.1  <  0.001  17.1  ±  5.9  29.6  ±  9.8  <  0.001
Change  in  SWS  (%)  12.4  ±  29.9  9.7  ±  28.4  25.7  ±  34.1  0.014  11.1  ±  29.8  30.8  ±  25.8  0.043
Data are mean ± standard deviation or number (%). CMR: cardiac magnetic resonance; HF: heart failure; LV: left ventricle; LVEDV: left ventricular end-diastolic volume; LVEF: left
ventricular ejection fraction; LVESV: left ventricular end-systolic volume; MVO: microvascular obstruction; SWS: systolic wall stress.
a Comparison of patients with and without HF.
b P < 0.05 when comparing baseline with 3-month CMR results (Wilcoxon test).
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Figure 2. Scatter plot showing the relationship between initial infarct size and systolic wall stress (SWS) measured by cardiac magnetic
r
e
esonance imaging, with initial and follow-up left ventricular volumes a
nd-systolic volume.nd left ventricular ejection fraction (LVEF). LVESV: left ventricular
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Table  3  Baseline  characteristics  according  to  systolic  wall  stress  quartiles.
SWS  quartiles  Pa
Q1  Q2  Q3  Q4
Age  (years)  53  ±  10.4  56.2  ±  11.4  59.7  ±  11.2  62.5  ±  11.1  0.001
BMI  (kg/m2) 27.1 ±  4 27.2  ±  4 26.9  ±  4.4  27.4  ±  3.9  0.97
Risk  factors
Male  37  (86.0) 35  (83.3) 36  (85.7) 32  (76.2) 0.49
Hypertension  12  (27.9)  16  (38.1)  14  (33.3)  15  (35.7)  0.77
Diabetes  mellitus  6  (14.0)  8  (29.0)  5  (11.9)  5  (11.9)  0.76
Hypercholesterolaemia  24  (55.8)  26  (61.9)  18  (42.9)  17  (40.5)  0.13
Tobacco  use  23  (53.5)  20  (47.6)  17  (40.5)  13  (31.0)  0.38
Characteristics  at  admission
SBP  (mmHg)  139  ±  27.6  145.8  ±  31.8  138  ±  27.9  142.7  ±  19.2  0.56
Heart  rate  (beats/min)  73.1  ±  17.9  76.5  ±  20.0  71.8  ±  16.0  79.7  ±  19.2  0.22
LAD  culprit  lesion  22  (51.2)  21  (50.0)  16  (38.1)  31  (73.8)  0.008
Multivessel  disease  13  (30.2)  19  (45.2)  20  (47.6)  19  (45.2)  0.42
Creatinine  (mol/L)  81.7  ±  19.4  88.9  ±  40.2  82.8  ±  21.6  83.6  ±  23  0.64
Blood  glucose  (mmol/L) 8.9  ±  4.3  10  ±  10.4  8.7  ±  4.9  8.2  ±  2.8  0.68
Creatine  kinase  peak  (IU/L)  2436  ±  1988  2827  ±  2098  3055  ±  1849  4148  ±  2488  0.003
HbA1c  (%) 6.1 ±  1.5  6.1  ±  1  6.2  ±  1.4  6.1  ±  1  1.00
Haemoglobin  (g/dL) 14.6  ±  1.6 15.4  ±  1.2  15.0  ±  1.3  15.0  ±  2.1  0.19
Initial  CMR  assessment
SBP  during  CMR  (mmHg) 114.5  ±  21.1 121.6  ±  16  120.1  ±  17.5  120.5  ±  14.6  0.26
LVEDV  index  (mL/m2) 74.9  ±  12.3 82.6  ±  13.9 88.2  ±  15.4  99.6  ±  16.8  <  0.001
LVESV  index  (mL/m2) 34.9  ±  8.5 40.5  ±  9.1  46.7  ±  10.7  62.8  ±  16.1  <  0.001
LVEF  (%) 53.4  ±  7.4 50.9  ±  7.2 47  ±  8.1  37.4  ±  9.1  <  0.001
LV  mass  index  (g/m2) 59.7  ±  9 58.2  ±  15.1 55.3  ±  9.9 61  ±  11.2  0.16
Infarct  size  (%) 18  ±  13 18.2  ±  10.2 21.7  ±  12.7  29.4  ±  13  <  0.001
MVO  19  (44.2) 25  (59.5) 25  (59.5) 27  (64.3)  0.19
Data are mean ± standard deviation or number (%). BMI: body mass index; CMR: cardiac magnetic resonance; HbA1c: glycated
haemoglobin; LAD: left anterior descending artery; LV: left ventricle; LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular
ejection fraction; LVESV: left ventricular end-systolic volume; MVO: microvascular obstruction; SBP: systolic blood pressure; SWS:
systolic wall stress.
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pa Analysis of variance.
On  multivariable  analysis,  infarct  size  (OR  1.067,  95%
CI  1.036—1.099;  P  <  0.001)  and  age  (OR  1.050,  95%  CI
1.005—1.097;  P  =  0.029)  were  the  only  signiﬁcant  indepen-
dent  predictors  of  predischarge  HF.  SWS  (hazard  ratio  [HR]
1.170,  95%  CI  1.070—1.278;  P  =  0.001)  and  heart  rate  at
admission  (HR  1.041,  95%  CI  1.010—1.072;  P =  0.009)  were
the  only  univariate  predictors  of  post-discharge  HF  (Table  3).
The  patients  with  the  highest  initial  SWS  (>  19.6
103·N·m−2)  exhibited  higher  rates  of  post-discharge  HF.  Sen-
sitivity  and  speciﬁcity  were  64.3%  and  78.9%,  respectively,
with  a  negative  predictive  value  of  95.9%.
Post-discharge  HF-free  survival  according  to  SWS  quartile
is  displayed  in  Fig.  3.
Predictors  of  any  level  of  HF  (n  =  35)  were  history  of
hypertension  (OR  2.820,  95%  CI  1.051—7.567;  P  =  0.040),
infarct  size  (OR  1.065,  95%  CI  1.033—1.097;  P  <  0.001)  and
SWS  (OR  1.113,  95%  CI  1.014—1.222;  P  =  0.023).Discussion
We  tested  several  of  the  CMR  ﬁndings  side  by  side
from  patients  with  ﬁrst  ST-segment  elevation  myocardial
b
rnfarction  and  optimal  medical  therapy  in  order  to
ccurately  determine  their  prognostic  value.  Before  com-
encing,  we  demonstrated  a low  incidence  of  events.
nfarct  size  was  an  independent  predictor  of  predischarge
F,  whereas  wall  stress  independently  predicted  post-
ischarge  HF.
Imbalances  between  pre-  and  post-discharge  HF  were
requently  reported.  The  improvement  in  reperfusion  ther-
pies,  greater  myocardial  salvage  and  reduced  extent  of
entricular  injury  may  have  reduced  direct  HF  events  com-
only  found  in  approximately  20%  of  patients  [1,20].  Taking
nto  account  the  decrease  in  HF  events  after  myocardial
nfarction  observed  over  the  last  decade  [21],  this  ratio  is
imilar  to  the  16.5%  of  patients  presenting  with  HF  during
nd  after  hospitalization  in  our  study  [1].  Interestingly,  it
as  been  shown  that  the  decrease  in  HF  events  was  substan-
ial  solely  in  reduced  LVEF  patients,  whereas  patients  with
n  LVEF  >  50%,  i.e.  without  substantial  myocardial  injury,
xhibited  no  favourable  change  in  HF  rates,  either  pre-  or
ost-discharge  [1].As  expected,  infarct  size  was  a  primary  predictor,  the
urden  of  myocardial  scarring  seemingly  playing  a crucial
ole  in  this  context.  Among  the  numerous  studies  conducted
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Figure 3. Time-to-event curves for heart failure according to ini-
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discharge  HF  after  myocardial  infarction,  while  infarct  sizeial systolic wall stress (SWS) quartiles.
n  the  myocardial  infarction  area,  infarct  size  has  appeared
s  one  of  the  strongest  predictors  of  left  ventricular  remod-
lling  [22,23].  Wu  et  al.  [8]  demonstrated  that  acute  infarct
ize,  which  is  independent  of  left  ventricular  stunning  and
oading,  is  a  stronger  predictor  of  future  cardiac  events  than
eft  ventricular  systolic  performance.  It  is  worth  noting  that
 recent  meta-analysis  demonstrated  that  infarct  size  was
rincipally  related  to  cardiovascular  events,  while  LVEF  was
ore  related  to  mortality  [5].
Nevertheless,  infarct  size  and  SWS  are  both  related  to
F,  but  are  quite  dissimilar  variables.  Even  if  infarct  size
as  shown  as  a  determinant  of  SWS,  their  direct  correla-
ion  remained  only  moderate  (r  =  0.405;  P  <  0.001)  (Fig.  1).
all  stress  is  a  more  dynamic  variable  that  integrates  ﬁll-
ng  conditions,  SBP,  wall  thickness  and  curvature  radius.
hereas  many  factors  have  been  revealed  as  correlating
ith  LVR  and  prognosis  —  including  anterior  infarction  [24],
ecrease  in  LVEF  [6],  absence  of  reperfusion  [25],  infarct
ize  [8,22,23,26]  and  presence  of  MVO  [27,28]  —  in  our  study,
hese  variables  were  only  univariate  predictors  of  post-
ischarge  HF.  This  supports  the  hypothesis  that  SWS  may
ather  various  aspects  of  post-infarction  myocardial  injury.
Our  results  have  highlighted  the  pre-eminent  role  SWS
lays  even  before  systolic  dysfunction  or  myocardial  ﬁbrosis.
his  concern  was  informed  by  results  in  non-ischemic  car-
iomyopathy,  where  shear  stress  was  found  to  be  related  to
-type  natriuretic  peptide  [29],  and  was  also  consistent  with
revious  studies  that  have  demonstrated  the  relationship
etween  SWS  and  both  remodelling  [6]  and  post-discharge
ardiac  events  [11].
The  patients  who  presented  with  post-discharge  HF
xhibited  higher  SWS  than  early  HF  patients  on  initial
nd  follow-up  assessment.  Interestingly,  they  also  exhib-
ted  more  signiﬁcant  changes  in  SWS  (Table  2).  This  dynamic
spect  suggests  that  SWS  plays  a  very  early  role  in  left
a
n
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entricular  remodelling,  as  well  as  the  existence  of  a  vicious
ircle  that  increases  shear  stress  in  the  months  to  follow  [6].
One  element  of  great  value  in  our  study  was  that  all
atients  received  optimal  medical  therapy,  including  beta-
lockers  and  angiotensin-converting  enzyme  inhibitors,  thus
ontrolling  the  neurohormonal  system  according  to  current
uidelines  [30,31].  Aldosterone  blockers  were  administered
o  patients  with  poor  left  ventricular  function  and  diabetes
r  HF.  Yet,  recent  data  showed  that  aldosterone  blockers
ad  a beneﬁcial  impact  in  an  unselected  population  with
yocardial  infarction  [32].  To  the  best  of  our  knowledge,
here  are  currently  no  published  data  concerning  medi-
al  optimization  in  accordance  with  wall  stress  assessment.
owever,  the  blockage  of  the  renin-angiotensin-aldosterone
ystem  is  effective  in  controlling  not  only  post-load,  but
lso  LVR  [33]  and  the  microstructural  remodelling  process
4,34],  which  may  play  a  role  in  the  increase  in  SWS.  The
anagement  of  at-risk  patients  identiﬁed  by  SWS  in  term
f  aggressive  therapies  and  close  monitoring  remains  to  be
tudied.
tudy limitations
his  study  applied  the  global  left  ventricular  SWS,  a  tech-
ique  that  does  not  take  into  account  the  speciﬁcity  of  SWS
n  the  necrotic  area.  Therefore,  the  study  of  SWS  in  an  area
hat  corresponds  exactly  to  that  of  LGE  on  the  one  hand,
nd  the  healthy  remote  myocardium  on  the  other,  could
mprove  measurement  accuracy  and  provide  a  more  pre-
ise  assessment  of  the  relationship  with  cardiac  events  and
emodelling.
Most  predischarge  HF  events  occurred  before  the  ﬁrst
MR  assessment.  This  may  have  reduced  the  impact  of  SWS
nd  LVEF  in  the  multivariable  model,  because  of  poten-
ial  changes  caused  by  myocardial  stunning  and  the  early
emodelling  process.  Longitudinal  and  daily  assessment  of
yocardial  function  and  volumes  should  be  performed  in
rder  to  elucidate  this  issue.
Within  the  study  population,  there  were  a  few  patients
ith  HF  during  follow-up  (14  of  169).  We  sought  to  inves-
igate  a  homogenous  dataset  of  patients  presenting  with
cute  myocardial  infarction  and  undergoing  modern  mana-
ement  modalities,  according  to  the  latest  guidelines  [31].
ll  patients  received  optimal  treatment  with  early  angio-
lasty.  Our  patients  thus  presented  an  extremely  low  rate
f  events  compared  with  previous  studies  in  this  domain
11]. Nevertheless,  this  is  consistent  with  recent  reports
1,2,32,35]  that  have  demonstrated  constantly  decreasing
ates  of  cardiovascular  events  in  post-myocardial  infarc-
ion  patients.  Furthermore,  our  results  were  taken  from  our
ataset,  depicting  the  primary  variables,  thus  allowing  for
he  possibility  that  relevant  factors  pertaining  to  the  post-
nfarction  setting  were  missed  [25].
onclusions
WS  was  found  to  be  an  independent  predictor  of  post-nd  microvascular  obstruction  were  not.  It  is  interesting  to
ote  that  SWS  continued  to  increase  thereafter  and  was
ound  to  be  extremely  signiﬁcant  in  HF  patients.  Further
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investigation  is  necessary  to  determine  whether  SWS  should
be  targeted  in  order  to  optimize  post-myocardial  infarction
therapies  and  prevent  HF.
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